This Plain Language Summary of Publication from Future Cardiology describes the results from an ongoing, long-term extension study looking at the survival rates of people with transthyretin amyloid cardiomyopathy being treated with tafamidis.

Read the full article here.

The original article on which this Plain Language Summary is based is titled ‘Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy’ and was published in Circulation: Heart Failure. Read the original article here.